secwatch.observer — SEC 8-K summary
======================================

Issuer:     BIO-RAD LABORATORIES, INC. (BIO)
CIK:        0000012208
Form:       8-K
Filed at:   2023-01-10T23:59:59+00:00
Accession:  0000012208-23-000009
Event type: other
Sentiment:  neutral
Materiality: 0.10
Item codes: 7.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Bio-Rad to present at J.P. Morgan Healthcare Conference on Jan 10, 2023
-----------------------------------------------------------------------

- President & CEO Norman Schwartz to present company overview at 4:30 p.m. PT.
- Q&A session with EVP/COO Andrew Last and EVP/CFO Ilan Daskal.
- Webcast link available on investor relations section of bio-rad.com.
- No specific financial results or material disclosures provided in the filing.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/12208/000001220823000009/0000012208-23-000009-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/12208/000001220823000009/bio-20230110.htm
  HTML page:      https://secwatch.observer/filing/0000012208-23-000009

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer